| JXSB2400153 | AMG 451 | Rocatinlimab | Injection | Biological Products(1) | Supplementary Application | 2024-11-22 | | Amgen Inc | | | view |
| JXSB2400147 | AMG 451 | Rocatinlimab | Injection | Biological Products(1) | Supplementary Application | 2024-11-19 | | Amgen Inc | | | view |
| JXSB2400146 | AMG 451 | Rocatinlimab | Injection | Biological Products(1) | Supplementary Application | 2024-11-19 | | Amgen Inc | | | view |
| JXSB2400143 | AMG 451 | Rocatinlimab | Injection | Biological Products(1) | Supplementary Application | 2024-11-09 | | Amgen Inc | | | view |
| JXSL2400118 | AMG 451 | Rocatinlimab | Injection | Biological Products(1) | Import Drug Application | 2024-07-02 | | | | | view |
| JXSL2400047 | AMG 451 | Rocatinlimab | Injection | Biological Products(1) | Import Drug Application | 2024-02-21 | | | | | view |
| JXSB2300152 | AMG 451 | Rocatinlimab | Injection | Biological Products(1) | Supplementary Application | 2023-12-08 | | Amgen Inc | | | view |
| JXSB2300116 | AMG 451 | Rocatinlimab | Injection | Biological Products(1) | Supplementary Application | 2023-09-28 | | Amgen Inc | | | view |
| JXSB2300100 | AMG 451 | Rocatinlimab | Injection | Biological Products(1) | Supplementary Application | 2023-08-12 | | Amgen Inc | | | view |
| JXSB2300099 | AMG 451 | Rocatinlimab | Injection | Biological Products(1) | Supplementary Application | 2023-08-11 | | Amgen Inc | | | view |
| JXSL2300064 | AMG 451 | Rocatinlimab | Injection | Biological Products(1) | Import Drug Application | 2023-04-05 | | | | | view |
| JXSL2200210 | AMG 451 | Rocatinlimab | Injection | Biological Products(1) | Import Drug Application | 2022-12-23 | | | | | view |
| JXSL2200209 | AMG 451 | Rocatinlimab | Injection | Biological Products(1) | Import Drug Application | 2022-12-23 | | | | | view |
| JXSL2200211 | AMG 451 | Rocatinlimab | Injection | Biological Products(1) | Import Drug Application | 2022-12-23 | | | | | view |
